Targeting PIK3CA and CDKN2A alterations in Esophageal Adenocarcinoma with Alpelisib and Palbociclib

被引：0
|
作者：
Rustgi, Naryan
Ryan, Thomas
Cho, Jin
Moy, Ryan
Yoon, Sam
Ryeom, Sandra
Yoon, Changhwan
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-C157
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C157
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PIK3CA alterations in primary (de novo) and secondary glioblastomas
    Kita, Daisuke
    Yonekawa, Yasuhiro
    Weller, Michael
    Ohgaki, Hiroko
    ACTA NEUROPATHOLOGICA, 2007, 113 (03) : 295 - 302
  • [22] 治疗PIK3CA相关的过度生长谱系疾病新药：Alpelisib
    杜庆伟
    徐瑛
    闫雪生
    袁敏
    张继兰
    孟静
    黄文倩
    郭昭丽
    中国合理用药探索, 2023, 20 (05) : 43 - 47
  • [23] A phase-2 trial of neoadjuvant alpelisib and nab-paclitaxel in anthracycline refractory triple negative breast cancers with PIK3CA or PTEN alterations
    Damodaran, Senthil
    Litton, Jennifer K.
    Hess, Kenneth R.
    Eppig, Colleen T.
    Grzegorzewski, Krzysztof J.
    Meric-Bernstam, Funda
    Wistuba, Ignacio I.
    White, Jason B.
    Rauch, Gaiane M.
    Candelaria, Rosalind P.
    Adrada, Beatriz E.
    Lim, Bora
    Moulder, Stacy L.
    Tripathy, Debu
    CANCER RESEARCH, 2020, 80 (04)
  • [24] 肌上皮样分化的化生性乳腺癌中存在CDKN2A缺失与PIK3CA突变
    Bartels S
    van Luttikhuizen J L
    Christgen M
    林心语
    余英豪
    临床与实验病理学杂志, 2019, 35 (03) : 364 - 364
  • [25] GENOMIC CHARACTERISTIC ANALYSIS IN SQUAMOUS CELL CARCINOMA AND ADENOCARCINOMA OF CERVIX IDENTIFIES ALPELISIB AS A THERAPEUTIC OPTION FOR PIK3CA MUTATIONAL CERVICAL CARCINOMA
    Cao, Canhui
    Wei, Ye
    Lin, Shitong
    Liu, Binhan
    Cheng, Sheng
    Zhu, Zhlxian
    Wu, Peng
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A1 - A2
  • [26] Targeting glutamine metabolism in PIK3CA mutant colorectal cancers
    Feng, Xiujing
    Hao, Yujun
    Wang, Zhenghe
    GENES & DISEASES, 2016, 3 (04) : 241 - 243
  • [27] PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma
    Ross, R. L.
    McPherson, H. R.
    Kettlewell, L.
    Shnyder, S. D.
    Hurst, C. D.
    Alder, O.
    Knowles, M. A.
    BMC CANCER, 2016, 16
  • [28] Effects of CDKN2A loss on evolution of esophageal adenocarcinoma depend on context and time
    Ciccarelli, Francesca D.
    NATURE CANCER, 2025, 6 (01) : 22 - 23
  • [29] PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma
    R. L. Ross
    H. R. McPherson
    L. Kettlewell
    S. D. Shnyder
    C. D. Hurst
    O. Alder
    M. A. Knowles
    BMC Cancer, 16
  • [30] Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance
    Nur Syafinaz Zainal
    Bernard Kok Bang Lee
    Zheng Wei Wong
    Iuan Sheau Chin
    Pei San Yee
    Chai Phei Gan
    Kein Seong Mun
    Zainal Ariff Abdul Rahman
    J.Silvio Gutkind
    Vyomesh Patel
    Sok Ching Cheong
    Cancer Biology & Medicine, 2019, 16 (02) : 264 - 275
12345